Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-01-01

AUTHORS

Kenneth E L McColl, Anthea Dickson, Adil El-Nujumi, Emad El-Omar, Andrew Kelman

ABSTRACT

OBJECTIVES: Eradication of Helicobacter pylori (H. pylori) infection markedly reduces the recurrence of duodenal and gastric ulcers. However, there is little information regarding its efficacy in resolving dyspeptic symptoms in ulcer patients. The primary aim of this study was to assess the effect of eradicating H. pylori infection on dyspeptic symptoms in ulcer patients. The secondary aim was to identify predictors of symptomatic response to H. pylori eradication. METHODS: A total of 97 dyspeptic patients with active duodenal and/or gastric ulceration associated with H. pylori infection and unrelated to NSAID use had the severity and character of their dyspeptic symptoms measured before and again 1-3 yr after H. pylori eradication therapy. RESULTS: Pretreatment, the median dyspepsia score was 12 (4-16). Posttreatment, 55% of those eradicated of H. pylori had resolution of dyspepsia (score <2) compared with 18% of those not eradicated of the infection (95% CI for difference, 11-62%). Of the ulcer patients 31% had symptoms and/or endoscopic evidence of coexisting gastroesophageal reflux disease (GERD) at initial presentation and this influenced the symptomatic response to eradication of H. pylori. Of the 22 patients with heartburn or acid reflux as the predominant presenting symptom, but no endoscopic esophagitis, only 27% experienced resolution of dyspepsia after H. pylori eradication, compared with 68% of the 59 without those as predominant symptoms (95% CI for difference, 18-63%). Only one of the five patients with coexisting endoscopic esophagitis at initial presentation experienced resolution of dyspepsia after H. pylori eradication. Symptomatic benefit was unrelated to time lapsed since the infection was eradicated. Only three of 50 subjects developed de novo GERD symptoms after eradication of H. pylori, whereas 21 of 36 subjects experienced resolution of GERD symptoms after eradication of the infection. CONCLUSIONS: A substantial proportion of ulcer patients have symptoms and/or signs of coexisting GERD at initial presentation and this reduces the symptomatic benefit from H. pylori eradication. However, we have found no evidence that eradicating H. pylori induces de novo GERD symptoms in ulcer patients. More... »

PAGES

101

Identifiers

URI

http://scigraph.springernature.com/pub.10.1111/j.1572-0241.2000.01706.x

DOI

http://dx.doi.org/10.1111/j.1572-0241.2000.01706.x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000792023

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10638566


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amoxicillin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Ulcer Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastroesophageal Reflux", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Helicobacter Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Helicobacter pylori", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metronidazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Omeprazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Penicillins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptic Ulcer", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom", 
          "id": "http://www.grid.ac/institutes/grid.412947.d", 
          "name": [
            "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McColl", 
        "givenName": "Kenneth E L", 
        "id": "sg:person.013050256164.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013050256164.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom", 
          "id": "http://www.grid.ac/institutes/grid.412947.d", 
          "name": [
            "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dickson", 
        "givenName": "Anthea", 
        "id": "sg:person.0627567353.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627567353.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom", 
          "id": "http://www.grid.ac/institutes/grid.412947.d", 
          "name": [
            "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "El-Nujumi", 
        "givenName": "Adil", 
        "id": "sg:person.01226505162.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226505162.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom", 
          "id": "http://www.grid.ac/institutes/grid.412947.d", 
          "name": [
            "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "El-Omar", 
        "givenName": "Emad", 
        "id": "sg:person.0700142176.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700142176.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom", 
          "id": "http://www.grid.ac/institutes/grid.412947.d", 
          "name": [
            "University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kelman", 
        "givenName": "Andrew", 
        "id": "sg:person.0645442521.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645442521.62"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1111/j.1572-0241.1998.020_c.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031360401", 
          "https://doi.org/10.1111/j.1572-0241.1998.020_c.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.1998.452_a.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003819396", 
          "https://doi.org/10.1111/j.1572-0241.1998.452_a.x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-01-01", 
    "datePublishedReg": "2000-01-01", 
    "description": "OBJECTIVES: Eradication of Helicobacter pylori (H. pylori) infection markedly reduces the recurrence of duodenal and gastric ulcers. However, there is little information regarding its efficacy in resolving dyspeptic symptoms in ulcer patients. The primary aim of this study was to assess the effect of eradicating H. pylori infection on dyspeptic symptoms in ulcer patients. The secondary aim was to identify predictors of symptomatic response to H. pylori eradication.\nMETHODS: A total of 97 dyspeptic patients with active duodenal and/or gastric ulceration associated with H. pylori infection and unrelated to NSAID use had the severity and character of their dyspeptic symptoms measured before and again 1-3 yr after H. pylori eradication therapy.\nRESULTS: Pretreatment, the median dyspepsia score was 12 (4-16). Posttreatment, 55% of those eradicated of H. pylori had resolution of dyspepsia (score <2) compared with 18% of those not eradicated of the infection (95% CI for difference, 11-62%). Of the ulcer patients 31% had symptoms and/or endoscopic evidence of coexisting gastroesophageal reflux disease (GERD) at initial presentation and this influenced the symptomatic response to eradication of H. pylori. Of the 22 patients with heartburn or acid reflux as the predominant presenting symptom, but no endoscopic esophagitis, only 27% experienced resolution of dyspepsia after H. pylori eradication, compared with 68% of the 59 without those as predominant symptoms (95% CI for difference, 18-63%). Only one of the five patients with coexisting endoscopic esophagitis at initial presentation experienced resolution of dyspepsia after H. pylori eradication. Symptomatic benefit was unrelated to time lapsed since the infection was eradicated. Only three of 50 subjects developed de novo GERD symptoms after eradication of H. pylori, whereas 21 of 36 subjects experienced resolution of GERD symptoms after eradication of the infection.\nCONCLUSIONS: A substantial proportion of ulcer patients have symptoms and/or signs of coexisting GERD at initial presentation and this reduces the symptomatic benefit from H. pylori eradication. However, we have found no evidence that eradicating H. pylori induces de novo GERD symptoms in ulcer patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1111/j.1572-0241.2000.01706.x", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1412991", 
        "issn": [
          "0002-9270", 
          "1572-0241"
        ], 
        "name": "The American Journal of Gastroenterology", 
        "publisher": "Wolters Kluwer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "95"
      }
    ], 
    "keywords": [
      "H. pylori eradication", 
      "gastroesophageal reflux disease", 
      "de novo GERD symptoms", 
      "pylori eradication", 
      "ulcer patients", 
      "H. pylori infection", 
      "GERD symptoms", 
      "dyspeptic symptoms", 
      "initial presentation", 
      "pylori infection", 
      "H. pylori", 
      "symptomatic benefit", 
      "reflux disease", 
      "endoscopic esophagitis", 
      "symptomatic response", 
      "H. pylori eradication therapy", 
      "predominant presenting symptom", 
      "pylori eradication therapy", 
      "Helicobacter pylori infection", 
      "NSAID use", 
      "dyspepsia score", 
      "patients 31", 
      "experienced resolution", 
      "eradication therapy", 
      "endoscopic evidence", 
      "presenting symptom", 
      "predominant symptom", 
      "acid reflux", 
      "dyspeptic patients", 
      "gastric ulcer", 
      "gastric ulceration", 
      "patients", 
      "secondary aim", 
      "symptoms", 
      "dyspepsia", 
      "infection", 
      "pylori", 
      "eradication", 
      "substantial proportion", 
      "esophagitis", 
      "primary aim", 
      "disease", 
      "presentation", 
      "little information", 
      "subjects", 
      "heartburn", 
      "ulceration", 
      "ulcers", 
      "recurrence", 
      "aim", 
      "therapy", 
      "reflux", 
      "severity", 
      "posttreatment", 
      "response", 
      "efficacy", 
      "evidence", 
      "total", 
      "scores", 
      "predictors", 
      "signs", 
      "benefits", 
      "pretreatment", 
      "years", 
      "proportion", 
      "yr", 
      "study", 
      "effect", 
      "use", 
      "time", 
      "impact", 
      "resolution", 
      "information", 
      "character"
    ], 
    "name": "Symptomatic benefit 1\u20133 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease", 
    "pagination": "101", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000792023"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1111/j.1572-0241.2000.01706.x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10638566"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1111/j.1572-0241.2000.01706.x", 
      "https://app.dimensions.ai/details/publication/pub.1000792023"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_340.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1111/j.1572-0241.2000.01706.x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2000.01706.x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2000.01706.x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2000.01706.x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1111/j.1572-0241.2000.01706.x'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      21 PREDICATES      118 URIs      108 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1111/j.1572-0241.2000.01706.x schema:about N00b8f8d7745349329c5dc5065e8cb63e
2 N155586288dcd41b69ce3557c4dbb8df3
3 N1da8b70a4e6e438baf0149db71bf5a2f
4 N25276d79cb214f8fb7cd60a6559dcfe7
5 N408acee9619a47dfa7f27feb31beb584
6 N4693edfec83144b59679f1b3c9fbba19
7 N5573a6615886423482069e333a51e169
8 N5e3ded65445246e19a14e54369b45ff4
9 N5fda1c2003c4497f8e048da7c7ef9cd2
10 N6f06c365979f471aa9e4627dca7320d1
11 N82f660b01b6a4bd7af10dfd85c6b8e5d
12 N96055d6d508b451795b8ad04c26e8445
13 N9eb7bf66091e4db2ad9b70dd62285d9f
14 Nb8bb0322da9d4c199bd8fdaf29e906ec
15 Ncfd7ea3f72c94d52852b2cbab0219966
16 Nd7be3a4c894548e9bf8929779320fdbe
17 Nfe42062387b64aee95ae3290b94dd241
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N166624bb5b4641d89e90a725c303ec66
21 schema:citation sg:pub.10.1111/j.1572-0241.1998.020_c.x
22 sg:pub.10.1111/j.1572-0241.1998.452_a.x
23 schema:datePublished 2000-01-01
24 schema:datePublishedReg 2000-01-01
25 schema:description OBJECTIVES: Eradication of Helicobacter pylori (H. pylori) infection markedly reduces the recurrence of duodenal and gastric ulcers. However, there is little information regarding its efficacy in resolving dyspeptic symptoms in ulcer patients. The primary aim of this study was to assess the effect of eradicating H. pylori infection on dyspeptic symptoms in ulcer patients. The secondary aim was to identify predictors of symptomatic response to H. pylori eradication. METHODS: A total of 97 dyspeptic patients with active duodenal and/or gastric ulceration associated with H. pylori infection and unrelated to NSAID use had the severity and character of their dyspeptic symptoms measured before and again 1-3 yr after H. pylori eradication therapy. RESULTS: Pretreatment, the median dyspepsia score was 12 (4-16). Posttreatment, 55% of those eradicated of H. pylori had resolution of dyspepsia (score <2) compared with 18% of those not eradicated of the infection (95% CI for difference, 11-62%). Of the ulcer patients 31% had symptoms and/or endoscopic evidence of coexisting gastroesophageal reflux disease (GERD) at initial presentation and this influenced the symptomatic response to eradication of H. pylori. Of the 22 patients with heartburn or acid reflux as the predominant presenting symptom, but no endoscopic esophagitis, only 27% experienced resolution of dyspepsia after H. pylori eradication, compared with 68% of the 59 without those as predominant symptoms (95% CI for difference, 18-63%). Only one of the five patients with coexisting endoscopic esophagitis at initial presentation experienced resolution of dyspepsia after H. pylori eradication. Symptomatic benefit was unrelated to time lapsed since the infection was eradicated. Only three of 50 subjects developed de novo GERD symptoms after eradication of H. pylori, whereas 21 of 36 subjects experienced resolution of GERD symptoms after eradication of the infection. CONCLUSIONS: A substantial proportion of ulcer patients have symptoms and/or signs of coexisting GERD at initial presentation and this reduces the symptomatic benefit from H. pylori eradication. However, we have found no evidence that eradicating H. pylori induces de novo GERD symptoms in ulcer patients.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N12b1573f77fc4cb681c726954a09506f
29 N3ce2fb7d2ebc42ebb0f7c6cf8f4e5b2b
30 sg:journal.1412991
31 schema:keywords GERD symptoms
32 H. pylori
33 H. pylori eradication
34 H. pylori eradication therapy
35 H. pylori infection
36 Helicobacter pylori infection
37 NSAID use
38 acid reflux
39 aim
40 benefits
41 character
42 de novo GERD symptoms
43 disease
44 dyspepsia
45 dyspepsia score
46 dyspeptic patients
47 dyspeptic symptoms
48 effect
49 efficacy
50 endoscopic esophagitis
51 endoscopic evidence
52 eradication
53 eradication therapy
54 esophagitis
55 evidence
56 experienced resolution
57 gastric ulcer
58 gastric ulceration
59 gastroesophageal reflux disease
60 heartburn
61 impact
62 infection
63 information
64 initial presentation
65 little information
66 patients
67 patients 31
68 posttreatment
69 predictors
70 predominant presenting symptom
71 predominant symptom
72 presentation
73 presenting symptom
74 pretreatment
75 primary aim
76 proportion
77 pylori
78 pylori eradication
79 pylori eradication therapy
80 pylori infection
81 recurrence
82 reflux
83 reflux disease
84 resolution
85 response
86 scores
87 secondary aim
88 severity
89 signs
90 study
91 subjects
92 substantial proportion
93 symptomatic benefit
94 symptomatic response
95 symptoms
96 therapy
97 time
98 total
99 ulcer patients
100 ulceration
101 ulcers
102 use
103 years
104 yr
105 schema:name Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease
106 schema:pagination 101
107 schema:productId N342a0e35cf1f47dfba7ddcf6530616bd
108 Nb83bd9aa159245e8a84a42ba4f5ca52b
109 Nd1bfb90375b9446d8d38f2b98aa6b7ba
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000792023
111 https://doi.org/10.1111/j.1572-0241.2000.01706.x
112 schema:sdDatePublished 2022-12-01T06:23
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher Nd9adebf920b9442b8d5152d37738c73c
115 schema:url https://doi.org/10.1111/j.1572-0241.2000.01706.x
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N00b8f8d7745349329c5dc5065e8cb63e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Aged
121 rdf:type schema:DefinedTerm
122 N12b1573f77fc4cb681c726954a09506f schema:volumeNumber 95
123 rdf:type schema:PublicationVolume
124 N155586288dcd41b69ce3557c4dbb8df3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Gastroesophageal Reflux
126 rdf:type schema:DefinedTerm
127 N166624bb5b4641d89e90a725c303ec66 rdf:first sg:person.013050256164.36
128 rdf:rest Ncee50bfd3cd745d4a2ab2325756e7a6f
129 N1da8b70a4e6e438baf0149db71bf5a2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Anti-Bacterial Agents
131 rdf:type schema:DefinedTerm
132 N25276d79cb214f8fb7cd60a6559dcfe7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Peptic Ulcer
134 rdf:type schema:DefinedTerm
135 N342a0e35cf1f47dfba7ddcf6530616bd schema:name pubmed_id
136 schema:value 10638566
137 rdf:type schema:PropertyValue
138 N3ce2fb7d2ebc42ebb0f7c6cf8f4e5b2b schema:issueNumber 1
139 rdf:type schema:PublicationIssue
140 N408acee9619a47dfa7f27feb31beb584 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Penicillins
142 rdf:type schema:DefinedTerm
143 N4693edfec83144b59679f1b3c9fbba19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Amoxicillin
145 rdf:type schema:DefinedTerm
146 N489ab7d8396546dcaf486e50705c0b66 rdf:first sg:person.0645442521.62
147 rdf:rest rdf:nil
148 N5573a6615886423482069e333a51e169 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Anti-Ulcer Agents
150 rdf:type schema:DefinedTerm
151 N5e3ded65445246e19a14e54369b45ff4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Middle Aged
153 rdf:type schema:DefinedTerm
154 N5fda1c2003c4497f8e048da7c7ef9cd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Male
156 rdf:type schema:DefinedTerm
157 N6f06c365979f471aa9e4627dca7320d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Female
159 rdf:type schema:DefinedTerm
160 N7bbf4424cb94405dbc2b2665c202515a rdf:first sg:person.0700142176.81
161 rdf:rest N489ab7d8396546dcaf486e50705c0b66
162 N82f660b01b6a4bd7af10dfd85c6b8e5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Helicobacter Infections
164 rdf:type schema:DefinedTerm
165 N96055d6d508b451795b8ad04c26e8445 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Drug Therapy, Combination
167 rdf:type schema:DefinedTerm
168 N9eb7bf66091e4db2ad9b70dd62285d9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Metronidazole
170 rdf:type schema:DefinedTerm
171 Nb83bd9aa159245e8a84a42ba4f5ca52b schema:name dimensions_id
172 schema:value pub.1000792023
173 rdf:type schema:PropertyValue
174 Nb8bb0322da9d4c199bd8fdaf29e906ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Adult
176 rdf:type schema:DefinedTerm
177 Ncee50bfd3cd745d4a2ab2325756e7a6f rdf:first sg:person.0627567353.93
178 rdf:rest Nd2d34aca22d24269a3c2571544180f03
179 Ncfd7ea3f72c94d52852b2cbab0219966 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Humans
181 rdf:type schema:DefinedTerm
182 Nd1bfb90375b9446d8d38f2b98aa6b7ba schema:name doi
183 schema:value 10.1111/j.1572-0241.2000.01706.x
184 rdf:type schema:PropertyValue
185 Nd2d34aca22d24269a3c2571544180f03 rdf:first sg:person.01226505162.99
186 rdf:rest N7bbf4424cb94405dbc2b2665c202515a
187 Nd7be3a4c894548e9bf8929779320fdbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Helicobacter pylori
189 rdf:type schema:DefinedTerm
190 Nd9adebf920b9442b8d5152d37738c73c schema:name Springer Nature - SN SciGraph project
191 rdf:type schema:Organization
192 Nfe42062387b64aee95ae3290b94dd241 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Omeprazole
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
199 schema:name Clinical Sciences
200 rdf:type schema:DefinedTerm
201 sg:journal.1412991 schema:issn 0002-9270
202 1572-0241
203 schema:name The American Journal of Gastroenterology
204 schema:publisher Wolters Kluwer
205 rdf:type schema:Periodical
206 sg:person.01226505162.99 schema:affiliation grid-institutes:grid.412947.d
207 schema:familyName El-Nujumi
208 schema:givenName Adil
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226505162.99
210 rdf:type schema:Person
211 sg:person.013050256164.36 schema:affiliation grid-institutes:grid.412947.d
212 schema:familyName McColl
213 schema:givenName Kenneth E L
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013050256164.36
215 rdf:type schema:Person
216 sg:person.0627567353.93 schema:affiliation grid-institutes:grid.412947.d
217 schema:familyName Dickson
218 schema:givenName Anthea
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627567353.93
220 rdf:type schema:Person
221 sg:person.0645442521.62 schema:affiliation grid-institutes:grid.412947.d
222 schema:familyName Kelman
223 schema:givenName Andrew
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645442521.62
225 rdf:type schema:Person
226 sg:person.0700142176.81 schema:affiliation grid-institutes:grid.412947.d
227 schema:familyName El-Omar
228 schema:givenName Emad
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700142176.81
230 rdf:type schema:Person
231 sg:pub.10.1111/j.1572-0241.1998.020_c.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031360401
232 https://doi.org/10.1111/j.1572-0241.1998.020_c.x
233 rdf:type schema:CreativeWork
234 sg:pub.10.1111/j.1572-0241.1998.452_a.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003819396
235 https://doi.org/10.1111/j.1572-0241.1998.452_a.x
236 rdf:type schema:CreativeWork
237 grid-institutes:grid.412947.d schema:alternateName University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom
238 schema:name University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom
239 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...